Multifaceted Function of MicroRNA-299-3p Fosters an Antitumor Environment Through Modulation of Androgen Receptor and VEGFA Signaling Pathways in Prostate Cancer
暂无分享,去创建一个
Jong Y. Park | R. Chakrabarti | A. Berglund | T. Andl | Kavya Ganapathy | Md. Faqrul Hasan | Stephen J. Staklinski | Richard Ottman
[1] M. Li,et al. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer. , 2019, European review for medical and pharmacological sciences.
[2] W. Fan,et al. The role and mechanisms of action of microRNAs in cancer drug resistance , 2019, Clinical Epigenetics.
[3] X. Chen,et al. MiR-299-3p functions as a tumor suppressor in thyroid cancer by regulating SHOC2. , 2019, European review for medical and pharmacological sciences.
[4] Xinghua Jiang,et al. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1. , 2018, Bulletin du cancer.
[5] Kunning Wang,et al. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] Ruiyang Zhao,et al. MicroRNA-299-3p regulates proliferation, migration and invasion of human ovarian cancer cells by modulating the expression of OCT4. , 2018, Archives of biochemistry and biophysics.
[7] Jiachang Hu,et al. Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway , 2018, Bioscience reports.
[8] Yong Dai,et al. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] N. Seki,et al. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer , 2017, British Journal of Cancer.
[10] Yiqun Shao,et al. MicroRNA‐218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer , 2017, Molecular carcinogenesis.
[11] S. Wölfl,et al. Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis , 2017, PloS one.
[12] A. Joshua,et al. AR Signaling and the PI3K Pathway in Prostate Cancer , 2017, Cancers.
[13] G. Fraizer,et al. The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer , 2017, Cancers.
[14] H. Beltran,et al. Emerging Variants of Castration-Resistant Prostate Cancer , 2017, Current Oncology Reports.
[15] R. Chakrabarti,et al. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer , 2016, Oncotarget.
[16] Yong Peng,et al. The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.
[17] Steven J. M. Jones,et al. The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.
[18] Yan Dai,et al. MicroRNA-299-3p promotes the sensibility of lung cancer to doxorubicin through directly targeting ABCE1. , 2015, International journal of clinical and experimental pathology.
[19] N. Lu,et al. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition , 2015, Cell adhesion & migration.
[20] A. Zoubeidi,et al. Targeting the PI3K/Akt pathway in prostate cancer: challenges and opportunities (review). , 2014, International journal of oncology.
[21] J. Li,et al. A functional variant in miR-143 promoter contributes to prostate cancer risk , 2014, Archives of Toxicology.
[22] A. Levine,et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells , 2014, Oncogene.
[23] G. Quan,et al. The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton , 2013, Prostate cancer.
[24] Yan Huang,et al. Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer , 2013, PloS one.
[25] G. Fraizer,et al. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site , 2013, Molecular Cancer.
[26] V. Odero-Marah,et al. The role of Snail in prostate cancer , 2012, Cell adhesion & migration.
[27] M. Gleave,et al. Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer. , 2012, Molecular endocrinology.
[28] Shafiq A. Khan,et al. Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells. , 2012, Asian journal of andrology.
[29] K. Jennbacken,et al. Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang‐2 , 2012, The Prostate.
[30] Jun Luo,et al. MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth , 2012, PloS one.
[31] D. Tindall,et al. Androgen receptor signaling in prostate cancer development and progression , 2011, Journal of carcinogenesis.
[32] K. Fizazi,et al. Targeting Continued Androgen Receptor Signaling in Prostate Cancer , 2011, Clinical Cancer Research.
[33] Majid I. Alsagabi,et al. Molecular and Cellular Pathobiology Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression , 2011 .
[34] S. Leivonen,et al. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. , 2011, Cancer research.
[35] M. Saegusa,et al. Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug. , 2009, The American journal of pathology.
[36] Yutaka Kawakami,et al. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. , 2009, Cancer cell.
[37] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[38] R. Vessella,et al. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. , 2009, Cancer research.
[39] B. Olsen,et al. Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. , 2008, Molecular biology of the cell.
[40] M. Waltham,et al. Vimentin and Epithelial-Mesenchymal Transition in Human Breast Cancer – Observations in vitro and in vivo , 2007, Cells Tissues Organs.
[41] H. Osada,et al. MicroRNAs in biological processes and carcinogenesis. , 2007, Carcinogenesis.
[42] Kenneth J. Pienta,et al. Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer , 2006, Clinical Cancer Research.
[43] B. Gumbiner,et al. Regulation of cadherin-mediated adhesion in morphogenesis , 2005, Nature Reviews Molecular Cell Biology.
[44] T. Byzova,et al. Metastatic Properties of Prostate Cancer Cells are Controlled by VEGF , 2004, Cell communication & adhesion.
[45] M. Gleave,et al. Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells , 1994, International journal of cancer.